Drug intelligence / Profile preview

chitosan-hyaluronate hybrid gel

Development stage
Unknown
Lead developer
Chi2Gel
Modality
Hydrogel Systems → Drug Delivery Systems
Administration
Intraarticular
01

Overview

Chitosan-hyaluronate hybrid gel is a self-forming, thermo-responsive hydrogel developed by Ain Shams University for the treatment of temporomandibular joint (TMJ) internal derangement, specifically Wilkes Stage III or IV. The formulation combines chitosan, a natural polysaccharide, with hyaluronic acid (hyaluronate), a key component of synovial fluid. Administered via intra-articular injection following arthroscopic lysis and lavage, the gel transitions into a solid-like state at body temperature. This thermo-responsive property allows for prolonged residence time within the joint space compared to standard hyaluronic acid injections, providing sustained lubrication, reducing pain, and improving joint mobility by addressing the rapid clearance typically seen with liquid injections.

Other names
Chitosan-Hyaluronate Gel Mixturechitosan-hyaluronic acid hybrid gel
02

Targets

RHAMM (Hyaluronan-mediated motility receptor)CD44 (CD44 antigen)

Beyond the preview

Go deeper on chitosan-hyaluronate hybrid gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chitosan-hyaluronate hybrid gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call